Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1650578
Max Phase: Preclinical
Molecular Formula: C17H17N5
Molecular Weight: 291.36
Molecule Type: Small molecule
Associated Items:
ID: ALA1650578
Max Phase: Preclinical
Molecular Formula: C17H17N5
Molecular Weight: 291.36
Molecule Type: Small molecule
Associated Items:
Synonyms (1): DB1192
Synonyms from Alternative Forms(1):
Canonical SMILES: Cc1cc(C(=N)N)ccc1-c1cc2cc(C(=N)N)ccc2[nH]1
Standard InChI: InChI=1S/C17H17N5/c1-9-6-10(16(18)19)2-4-13(9)15-8-12-7-11(17(20)21)3-5-14(12)22-15/h2-8,22H,1H3,(H3,18,19)(H3,20,21)
Standard InChI Key: WMNOADXUDNUMIO-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 291.36 | Molecular Weight (Monoisotopic): 291.1484 | AlogP: 2.71 | #Rotatable Bonds: 3 |
Polar Surface Area: 115.53 | Molecular Species: BASE | HBA: 2 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 11.73 | CX LogP: 1.99 | CX LogD: -2.81 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.38 | Np Likeness Score: -0.43 |
1. Gillingwater K, Kumar A, Anbazhagan M, Boykin DW, Tidwell RR, Brun R.. (2009) In vivo investigations of selected diamidine compounds against Trypanosoma evansi using a mouse model., 53 (12): [PMID:19786604] [10.1128/aac.00422-09] |
2. Farahat AA, Kumar A, Say M, Wenzler T, Brun R, Paul A, Wilson WD, Boykin DW.. (2017) Exploration of DAPI analogues: Synthesis, antitrypanosomal activity, DNA binding and fluorescence properties., 128 [PMID:28152428] [10.1016/j.ejmech.2017.01.037] |
Source(1):